thyroid-associated ophthalmopathy and eyelid closure insufficiency
Conditions
Interventions
Group with favorable corneal treatment outcomes:None
Group with unfavorable corneal treatment outcomes:None
Sponsors
The First Affiliated Hospital of Army Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1.Meets the diagnostic criteria for active orbitopathy (TAO) as outlined in the Chinese Guidelines for the Diagnosis and Treatment of Thyroid-Associated Ophthalmopathy (2022). 2.Presence of incomplete eyelid closure. 3.Throughout the treatment process, all patients underwent detailed corneal examinations both during their initial visits and throughout the follow-up period, with regular ocular assessments being conducted. 4.Complete case data and post-discharge follow-up records.
Exclusion criteria
Exclusion criteria: 1.Patients with thyroid-associated ophthalmopathy (TAO) who exhibit complete eyelid closure. 2.Patients with concomitant orbital space-occupying lesions, ocular trauma, or other ocular diseases. 3.Incomplete clinical data; 4.Patients unable to comply with post-discharge follow-up requirements.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The degree of eyelid closure;Smoking history;Course of the disease;Age;Hypercholesterolemia; | — |
Countries
China
Contacts
Public ContactWang Xiaolei
The First Affiliated Hospital of Army Medical University
Outcome results
None listed